Quick Links
You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers global resources for investors, journalists and media professionals. News and resources from our local affiliates can be viewed in the Local news section. If you are not an investor or journalist, click here.
TOKYO, February 13, 2023 – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) would like to express its deepest sympathy to victims of the earthquake in Turkey and Syria.
Astellas has pledged a donation as follows to support the victims and to assist in reconstruction efforts.
Contributor: Astellas Pharma Inc.
Donation to: Japanese Red Cross Society
Amount: JPY10,000,000
Astellas hopes for the earliest possible recovery in the affected areas.
Click below for a copy of the full press release
Follow us
